Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The endocannabinoid system: a drug discovery perspective.

Daniele Piomelli1

  • 1Department of Pharmacology, University of California, Irvine, CA 92697-4625, USA. piomelli@uci.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|July 28, 2005
PubMed
Summary

Endocannabinoids, naturally occurring compounds, interact with cannabinoid receptors (CB1 and CB2). Targeting these receptors offers potential therapeutic strategies for weight management, pain relief, and mood disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.

Cancer letters·2026
Same author

The endocannabinoid 2-arachidonoylglycerol mediates seasonal life-history transitions in a wild reptile.

The Journal of experimental biology·2026
Same author

Cannabis use patterns and perception of acute pain during brief abstinence: sex-dependent associations with circulating cannabinoid levels.

Psychopharmacology·2026
Same author

Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru<sup>®</sup>, vs an Oil-Based Formulation, Epidyolex<sup>®</sup>, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study.

CNS drugs·2026
Same author

Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice.

The Journal of pharmacology and experimental therapeutics·2026
Same author

A Schedule Shift, Not a Federal Green Light: What Cannabis Rescheduling to Schedule III Would Mean-and What It Would Not.

Cannabis and cannabinoid research·2026

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Endocannabinoids are endogenous lipid signaling molecules.
  • They interact with cannabinoid receptors (CB1 and CB2), similar to delta9-tetrahydrocannabinol.
  • These systems play roles in appetite, pain, and mood regulation.

Purpose of the Study:

  • To explore therapeutic opportunities targeting the endocannabinoid system.
  • To discuss drug discovery strategies for conditions like obesity, pain, and anxiety.

Main Methods:

  • Review of existing research on endocannabinoid signaling.
  • Discussion of pharmacological approaches targeting CB1 and CB2 receptors.
  • Exploration of inhibiting endocannabinoid degradation pathways.

Main Results:

  • CB1 receptor blockade shows potential for body weight reduction.
  • Activation of extracerebral cannabinoid receptors may alleviate pain.
  • Inhibiting endocannabinoid degradation could modulate pain and anxiety.

Conclusions:

  • The endocannabinoid system presents diverse targets for novel drug development.
  • Pharmacological modulation offers promising avenues for treating metabolic, pain, and mood disorders.

Related Experiment Videos